High Doses of Vascular Endothelial Growth Factor 165 Safely, but Transiently, Improve Myocardial Perfusion in No-Option Ischemic Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High Doses of Vascular Endothelial Growth Factor 165 Safely, but Transiently, Improve Myocardial Perfusion in No-Option Ischemic Disease

Published:2013-10 Issue:5 Volume:24 Page:298-306
ISSN:1946-6536
Container-title:Human Gene Therapy Methods
language:en
Short-container-title:Human Gene Therapy Methods

Author:

Giusti Imarilde I.¹,Rodrigues Clarissa G.¹²,Salles Felipe B.¹,Sant'Anna Roberto T.¹,Eibel Bruna¹,Han Sang W.³,Ludwig Eduardo¹,Grossman Gabriel¹,Prates Paulo Roberto L.¹,Sant'Anna João Ricardo M.¹,Filho Guaracy F. Teixeira¹,Markoski Melissa M.¹,Nesralla Ivo A.¹,Nardi Nance B.¹,Kalil Renato A.K.¹⁴

Affiliation:

1. Instituto de Cardiologia, Fundação Universitária de Cardiologia, Porto Alegre, 90620-000 Brazil.

2. Department of Surgery, Duke University, Durham, NC 27710.

3. Universidade Federal de São Paulo, São Paulo, 04021-001 Brazil.

4. Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, 90050-170 Brazil.

Publisher

Mary Ann Liebert Inc

Subject

Genetics(clinical),Pharmacology,Genetics,Applied Microbiology and Biotechnology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hgtb.2012.221

Reference22 articles.

1. Use of Human VEGF165 Gene for Therapeutic Angiogenesis in Coronary Patients: First Results

2. Validação da versão em português do Minnesota Living with Heart Failure Questionnaire

3. One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients**Drs. Isner and Schatz are stockholders of Vascular Genetics, Inc., the sponsor of this trial.

4. Effects of therapeutic angiogenesis with plasmid VEGF165 on ventricular function in a canine model of chronic myocardial infarction

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VEGFA Isoforms as Pro-Angiogenic Therapeutics for Cerebrovascular Diseases;Biomolecules;2023-04-20

2. Characteristics and Outcomes of Clinical Trials on Gene Therapy in Noncongenital Cardiovascular Diseases: Cross-sectional Study of Three Clinical Trial Registries;JMIR Formative Research;2022-04-21

3. Citrate-Saline-Formulated mRNA Delivery into the Heart Muscle with an Electromechanical Mapping and Injection Catheter Does Not Lead to Therapeutic Effects in a Porcine Chronic Myocardial Ischemia Model;Human Gene Therapy;2021-10-01

4. Characteristics and Outcomes of Clinical Trials on Gene Therapy in Noncongenital Cardiovascular Diseases: Cross-sectional Study of Three Clinical Trial Registries (Preprint);2021-09-28

5. Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation;Pharmaceutics;2021-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3